Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05700643 · ClinicalTrials.gov registry record · Phase 1
Montmorency Cherry Supplementation, Sleep, and Inflammation
A Phase 1 study, sponsored by Michigan State University.
- Completed
- Registry status
- Phase 1
- Development phase
- 34
- Enrollment target
NCT05700643 is a Phase 1 study that has completed, run by Michigan State University. The registered enrollment target is 34 participants.
The verdict
NCT05700643, a Phase 1 study, has completed, sponsored by Michigan State University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study will test the effects of Montmorency cherry supplementation on sleep outcomes and inflammatory biomarkers.
Interventions
- DIETARY_SUPPLEMENT Control
- DIETARY_SUPPLEMENT Montmorency cherry supplement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2023-02-18 |
| Est. Completion | 2024-04-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05700643
The ClinicalTrials.gov registry entry for NCT05700643 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Michigan State University, which has 120 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Control is the first listed.
NCT05700643 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05700643 about?
NCT05700643 is a clinical study titled "Montmorency Cherry Supplementation, Sleep, and Inflammation". This study will test the effects of Montmorency cherry supplementation on sleep outcomes and inflammatory biomarkers.
What is the current status of trial NCT05700643?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 34 participants. The study started on 2023-02-18. Estimated completion is 2024-04-17.
What interventions are being tested in trial NCT05700643?
The interventions under investigation include: Control (DIETARY_SUPPLEMENT), Montmorency cherry supplement (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05700643?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.